These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24515112)

  • 1. (-)-Epicatechin gallate (ECG) stimulates osteoblast differentiation via Runt-related transcription factor 2 (RUNX2) and transcriptional coactivator with PDZ-binding motif (TAZ)-mediated transcriptional activation.
    Byun MR; Sung MK; Kim AR; Lee CH; Jang EJ; Jeong MG; Noh M; Hwang ES; Hong JH
    J Biol Chem; 2014 Apr; 289(14):9926-35. PubMed ID: 24515112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbaketal A stimulates osteoblast differentiation through TAZ mediated Runx2 activation.
    Byun MR; Kim AR; Hwang JH; Sung MK; Lee YK; Hwang BS; Rho JR; Hwang ES; Hong JH
    FEBS Lett; 2012 Apr; 586(8):1086-92. PubMed ID: 22575641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression.
    Byun MR; Kim AR; Hwang JH; Kim KM; Hwang ES; Hong JH
    Bone; 2014 Jan; 58():72-80. PubMed ID: 24125755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ.
    Jang EJ; Jeong H; Kang JO; Kim NJ; Kim MS; Choi SH; Yoo SE; Hong JH; Bae MA; Hwang ES
    Br J Pharmacol; 2012 Mar; 165(5):1584-94. PubMed ID: 21913895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol.
    Byun MR; Jeong H; Bae SJ; Kim AR; Hwang ES; Hong JH
    Bone; 2012 Jan; 50(1):364-72. PubMed ID: 22108137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
    Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
    PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated osterix expression elicited by Runx2 and Dlx5 is required for the accelerated osteoblast differentiation in PP2A Cα-knockdown cells.
    Yang D; Okamura H; Qiu L
    Cell Biol Int; 2018 Apr; 42(4):403-410. PubMed ID: 29068100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation.
    Zhu W; He X; Hua Y; Li Q; Wang J; Gan X
    J Biol Chem; 2017 Jul; 292(27):11178-11188. PubMed ID: 28500134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.
    Xiong J; Almeida M; O'Brien CA
    Bone; 2018 Jul; 112():1-9. PubMed ID: 29626544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation.
    Addison WN; Pellicelli M; St-Arnaud R
    J Biol Chem; 2019 May; 294(20):8184-8196. PubMed ID: 30948508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activity.
    Lee KN; Jang WG; Kim EJ; Oh SH; Son HJ; Kim SH; Franceschi R; Zhang XK; Lee SE; Koh JT
    J Biol Chem; 2012 Jun; 287(23):18888-99. PubMed ID: 22493443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hes1 stimulates transcriptional activity of Runx2 by increasing protein stabilization during osteoblast differentiation.
    Suh JH; Lee HW; Lee JW; Kim JB
    Biochem Biophys Res Commun; 2008 Feb; 367(1):97-102. PubMed ID: 18162173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation.
    Hinoi E; Fujimori S; Wang L; Hojo H; Uno K; Yoneda Y
    J Biol Chem; 2006 Jun; 281(26):18015-24. PubMed ID: 16613847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteasome inhibitor bortezomib inhibits FGF-2-induced reduction of TAZ levels in osteoblast-like cells.
    Eda H; Aoki K; Kato S; Okawa Y; Takada K; Tanaka T; Marumo K; Ohkawa K
    Eur J Haematol; 2010 Jul; 85(1):68-75. PubMed ID: 20192985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF1 promotes osteogenic differentiation of mesenchymal stem cells derived from rat bone marrow by increasing TAZ expression.
    Xue P; Wu X; Zhou L; Ma H; Wang Y; Liu Y; Ma J; Li Y
    Biochem Biophys Res Commun; 2013 Apr; 433(2):226-31. PubMed ID: 23473758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.
    Zhu J; Shimizu E; Zhang X; Partridge NC; Qin L
    J Cell Biochem; 2011 Jul; 112(7):1749-60. PubMed ID: 21381079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poncirin promotes osteoblast differentiation but inhibits adipocyte differentiation in mesenchymal stem cells.
    Yoon HY; Yun SI; Kim BY; Jin Q; Woo ER; Jeong SY; Chung YS
    Eur J Pharmacol; 2011 Aug; 664(1-3):54-9. PubMed ID: 21550337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin-3-gallate stimulates myogenic differentiation through TAZ activation.
    Kim AR; Kim KM; Byun MR; Hwang JH; Park JI; Oh HT; Jeong MG; Hwang ES; Hong JH
    Biochem Biophys Res Commun; 2017 Apr; 486(2):378-384. PubMed ID: 28315325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.